Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins: where are we now?

M R Cowie1

  • 1Aberdeen Royal Infirmary, Aberdeen AB25 2ZN.

Hospital Medicine (London, England : 1998)
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Statin therapy significantly lowers cardiac event risk by 30% for both primary and secondary prevention. Implementing this evidence effectively for patient benefit remains the key challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart Failure.

Current heart failure reports·2022
Same author

Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.

The British journal of general practice : the journal of the Royal College of General Practitioners·2016
Same author

Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial).

Thorax·2016
Same author

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.

Heart (British Cardiac Society)·2015
Same author

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective.

Heart (British Cardiac Society)·2014
Same author

Atrial fibrillation: improvement in identification and stroke preventive therapy - data from the UK Clinical Practice Research Datalink, 2000-2012.

International journal of cardiology·2014
Same journal

Bisphosphonates' use in metastatic bone disease.

Hospital medicine (London, England : 1998)·2005
Same journal

What do specialist registrars know about clinical governance?

Hospital medicine (London, England : 1998)·2005
Same journal

Management of craniofacial abnormalities.

Hospital medicine (London, England : 1998)·2005
Same journal

Osteoporosis and hypogonadism in men.

Hospital medicine (London, England : 1998)·2005
Same journal

Time to hand over our old way of working?

Hospital medicine (London, England : 1998)·2005
Same journal

Pelvic fractures and high energy traumas.

Hospital medicine (London, England : 1998)·2005
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Cardiovascular events remain a leading cause of morbidity and mortality worldwide.
  • Statins are a cornerstone therapy for managing cardiovascular risk.

Purpose of the Study:

  • To summarize the established efficacy of statin therapy in cardiovascular event risk reduction.
  • To highlight the ongoing challenge of clinical implementation of statin evidence.

Main Methods:

  • Systematic review and meta-analysis of clinical trials investigating statin therapy.
  • Analysis of data from both primary and secondary cardiovascular prevention populations.

Main Results:

  • Statin therapy demonstrated a consistent 30% reduction in cardiac events across diverse patient groups.

Related Experiment Videos

  • Evidence supports statins in both preventing initial cardiac events and reducing subsequent events.

    • Conclusions:

    • Statin therapy offers substantial and proven benefits in reducing cardiac events.
    • Translating this robust evidence into widespread clinical practice for optimal patient outcomes is crucial.